Product Information
CYCLOPHOSPHAMIDE 50 MG CAPSULE is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $1.5553 per EA under NDC 00054038325. Its NADAC has been published 496 times since Nov 19, 2014.
FDA first approved this application on Sep 16, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054038325
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CYCLOPHOSPHAMIDEApproval Type
New Drug (NDA)
FDA Application
NDA203856FDA Approved
9/16/2013
TE Code
AB
On Market Since
9/16/2013
Price Statistics
The NADAC for CYCLOPHOSPHAMIDE 50 MG CAPSULE has been published 496 times since Nov 19, 2014, and over the history we have for it it has declined 82.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5553 per EA |
|---|---|
| All-time high | $11.1101 (May 13, 2020) |
| All-time low | $1.5189 (Jul 22, 2026) |
| 52-week high | $2.2072 |
| 52-week low | $1.5189 |
| Median price | $8.7994 |
| Average price | $7.3749 |
| Largest weekly change | -49.4% (Jul 19, 2023) |
| Weeks tracked | 496 |
| Tracking since | Nov 19, 2014 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CYCLOPHOSPHAMIDE 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOPHOSPHAMIDE 50 MG CAPSULE, manufactured by Hikma Pharmaceuticals USA Inc., is $1.5553 per EA (NDC 00054038325), effective Aug 19, 2026.
How has the price of CYCLOPHOSPHAMIDE 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CYCLOPHOSPHAMIDE 50 MG CAPSULE has declined 82.1%. It has been tracked across 496 weekly CMS publications since Nov 19, 2014.
What are the highest and lowest recorded NADAC prices for CYCLOPHOSPHAMIDE 50 MG CAPSULE?
Since Nov 19, 2014, the NADAC for CYCLOPHOSPHAMIDE 50 MG CAPSULE has ranged from a low of $1.5189 (Jul 22, 2026) to a high of $11.1101 (May 13, 2020), with a median of $8.7994 per EA.
Are there cheaper alternatives to CYCLOPHOSPHAMIDE 50 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CYCLOPHOSPHAMIDE 50 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures CYCLOPHOSPHAMIDE 50 MG CAPSULE?
CYCLOPHOSPHAMIDE 50 MG CAPSULE (NDC 00054038325) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.